세계 창상용 피부 대체물 시장 규모는 2022년 11억 8,100만 달러에서 2023년부터 2030년까지 예측 기간 동안 연평균 7.35%의 견고한 성장세를 보이며 2030년에는 20억 6,260만 달러에 달할 것으로 예상됩니다.
당뇨병성 족부궤양, 욕창, 정맥성 하지궤양과 같은 만성 상처의 증가로 인해 혁신적이고 효과적인 상처 치유 솔루션에 대한 수요가 급증하고 있습니다.
| 주요 시장 통계 | |
|---|---|
| 예측 기간 | 2023-2030년 |
| 2023년 평가 | 12억 5,550만 달러 |
| 2030년 전망 | 20억 6,260만 달러 |
| CAGR | 7.35% |
바이오소재의 기술 발전과 보다 효율적인 피부 대체품의 개발은 이러한 성장을 더욱 촉진하고 있습니다. 또한, 만성질환에 취약한 노인 인구의 증가와 전 세계 의료 인프라의 기능 확대도 시장 확대에 크게 기여하고 있습니다. 또한, 환자 예후를 개선하고 만성 창상과 관련된 전반적인 의료 비용을 절감하는 데 대한 관심이 높아지면서 시장 성장에 힘을 보태고 있습니다.
세계 시장에서는 북미가 지배적이며, 2022년에는 78.12%의 점유율을 차지할 것으로 예상됩니다. 이러한 높은 점유율은 인구 고령화, 당뇨병과 밀접한 관련이 있는 비만의 급격한 증가, 방사선 치료 후유증 등 여러 요인에 기인합니다. 이러한 요인들은 환자들이 창상용 피부 대체물을 더 많이 사용하게 만들었고, 이는 매출 성장으로 이어지고 있습니다. 아시아태평양, 유럽, 라틴아메리카 지역도 만성 창상 발생률의 급증, 혁신적인 제품 개발로 이어지는 기술 발전, 의료비 증가로 인해 큰 성장이 예상됩니다.
세계 창상용 피부 대체물 시장을 조사했으며, 시장 개요, 시장 규모 추정 및 예측, 지역별/주요 국가별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
Introduction of Wound Skin Substitutes
The global wound skin substitutes market, valued at $1,181.0 million in 2022, is on a robust growth trajectory and is anticipated to reach $2,062.6 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 7.35% between 2023 and 2030. Driven by the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, the market is witnessing a surge in demand for innovative and effective wound healing solutions.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2030 |
| 2023 Evaluation | $1,255.5 Million |
| 2030 Forecast | $2,062.6 Million |
| CAGR | 7.35% |
Technological advancements in biomaterials and the development of more efficient skin substitute products are further fueling this growth. Moreover, the rising geriatric population, which is more prone to chronic conditions, and the expanding capabilities of healthcare infrastructures globally are significant contributors to the market's expansion. This growth has also been supported by a growing focus on improving patient outcomes and reducing the overall healthcare costs associated with chronic wounds.
Regional Segmentation:
The global wound skin substitutes market has been dominated by North America, which held a 78.12% share in 2022. This significant share can be attributed to several factors, including an aging population, the steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. These factors have further boosted the adoption of wound skin substitutes among patients, thereby boosting revenue growth. Asia-Pacific, Europe, and Latin America regions are expected to witness significant growth in the wound skin substitutes market due to a surge in the incidence rate of chronic wounds, technological advancements leading to the development of innovative products, and increasing healthcare expenditure.
Recent Developments in the Wound Skin Substitutes Market
How can this report add value to an organization?
Product/Innovation Strategy: By understanding specific regional needs and preferences highlighted in the report, a company can tailor its product development to address local market demands effectively. This might include innovation in skin substitute materials that cater to prevalent wound types in a particular region.
Growth/Marketing Strategy: With detailed regional data, companies can craft precise marketing strategies that resonate with local healthcare providers and patients. This includes choosing the right channels and messages that appeal to the specific demographic and economic conditions of the region.
Competitive Strategy: The report provides an analysis of key competitors in the region, allowing companies to benchmark their products and strategies. Knowing the competitive landscape helps in positioning their offerings more effectively to capture market share.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
Primary Research:
The primary sources involve industry experts in wound skin substitutes, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
Secondary Research
Open Sources
The key data points taken from the secondary sources include:
Key Market Players and Competition Synopsis
The competitive landscape of the wound skin substitutes market has been characterized by the presence of several key players, each offering a range of specialized products. Coloplast, for instance, has made significant strides with products such as MariGen Shield, GraftGuide Mano, and GraftGuide Micro, which are tailored to address various aspects of wound care, particularly burns and complex wounds. The companies are not only innovating in product development but also expanding their market reach and setting industry standards in the treatment of complex wounds. This dynamic competitive environment underscores the continuous evolution and technological advancement within the wound care industry.
Some prominent names established in this market are: